Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2021

View Archived Issues

Clonal fitness study may steer future cancer therapy

WNK2 is differentially expressed in MYD88-mutated Waldenstrom macroglobulinemia

Beijing Tide Pharmaceutical discloses new ATR kinase inhibitors

Fochon Pharmaceuticals patents PI3K inhibitors

Guangzhou Fermion Technology identifies new SST4 receptor agonists

Shanghai Longwood Biopharmaceuticals synthesizes PD-1/PD-L1 interaction inhibitors

Nanjing Legend Biotechnology describes new simian ICP47-based therapeutic cells

PRGN-3007 shows promise for treating mantle-cell lymphoma

Sleep-seizure EEG associations in TgBDNF mouse model of epilepsy

Liver humanized NSG-PiZ mouse model developed to test HBV antiviral therapies

Targeting CXCL16 shows therapeutic effects in model of TNBC

3SBio's Sunshine Guojian subsidiary to develop Numab's NM-28 in Greater China area

CVL-218 shows promising potency and safety in preclinical models

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

TYME-19 demonstrates antiviral effect against SARS-CoV-2 in human lung epithelial cells

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...